Pharmaceutical quality of eight generics of ceftriaxone preparation for injection in Eastern Asia
Authors:
- Matthias AltermattMAMatthias Altermatt
- Yves RoggoYRYves Roggo
- Gabriel SchnetzlerGSGabriel Schnetzler
- 21 August 2014
- journal article
- research article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 27 (6) , 337-342
Abstract
To compare the pharmaceutical quality of original and generic ceftriaxone sodium preparations for injection produced in Eastern Asia. Standard physical and chemical laboratory tests were performed. Participants/material: Ceftriaxone (Rocephin®, Roche, Switzerland) was the reference material. Generics produced in China, India, and Indonesia were sampled in China and Myanmar within their expiration dates. Eight generics obtained from Eastern Asia markets in January 2013 were analysed. All eight generics failed the specifications in three or more tests. Residues of solvents and metals were detected in all generics, four were not particle free, and two were not sterile. All tested generic ceftriaxone products failed to meet the pharmaceutical quality standards of the branded original. The high levels of impurities and the identified contamination of particles and residues are of clinical concern, as they could impact tolerability and safety in patients in need of an effective parenteral antibiotic.Keywords
This publication has 20 references indexed in Scilit:
- Microbial contamination of single- and multiple-dose vials after opening in a pulmonary teaching hospitalThe Brazilian Journal of Infectious Diseases, 2013
- Generic Vancomycin Enriches Resistant Subpopulations of Staphylococcus aureus after Exposure in a Neutropenic Mouse Thigh Infection ModelAntimicrobial Agents and Chemotherapy, 2012
- Generic Vancomycin Products FailIn Vivodespite Being Pharmaceutical Equivalents of the InnovatorAntimicrobial Agents and Chemotherapy, 2010
- Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremiaJournal of Infection, 2009
- Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroximeJournal of Infection, 2008
- Are generic formulations of carvedilol of inferior pharmaceutical quality compared with the branded formulation?Current Medical Research and Opinion, 2006
- Pharmaceutical quality of generic isotretinoin products, compared with RoaccutaneCurrent Medical Research and Opinion, 2006
- A Survey of the Quality of Generic???Clarithromycin Products from???18 CountriesClinical Drug Investigation, 2005
- Serratia liquefaciensBloodstream Infections from Contamination of Epoetin Alfa at a Hemodialysis CenterNew England Journal of Medicine, 2001
- Ceftriaxone A Review of its Antibacterial Activity, Pharmacological Properties and Therapeutic UseDrugs, 1984